首页> 外国专利> Mesoporous silica particles and their use in drug delivery

Mesoporous silica particles and their use in drug delivery

机译:介孔二氧化硅颗粒及其在药物递送中的用途

摘要

A substantially monodisperse assemblage of particles 10 having interconnected nanopores 20 and a core 30 with a shell 40 disposed about the core 30 wherein the particles 10 have a cubic crystal form. In another aspect, a method for the sustained release of an active substance to an environment comprising adding an active substance to the particles 10, placing restrictions 50 in the interconnected nanopores 20 within the shell 40 by covalent bonding (preferably using dextran polymers) and placing the particles with the added active substance in the environment. The particles are preferably either nanoprous or mesoporous silica. Alternatively, a method for the manufacture of a plurality of monodisperse particles 10 comprising: mixing an ionic surfactant (preferably cetyltriethylammonium bromide) with an inorganic salt (preferably sodium sulfate) in hydrochloric acid; mixing a co-solvent with a nonionic surfactant (preferably a polyalkylene oxide) and an oxide source (preferably TEOS); and mixing the two together.
机译:具有相互连接的纳米孔20和核30的颗粒10的基本上单分散的集合体,该核具有围绕核30布置的壳40,其中颗粒10具有立方晶形。在另一方面,一种用于将活性物质持续释放到环境中的方法包括:将活性物质添加到颗粒10中,通过共价键合(优选地使用右旋糖酐聚合物)在外壳40内的互连纳米孔20中放置限制50,并放置环境中添加了活性物质的颗粒。颗粒优选是纳米级或中孔二氧化硅。或者,制造多个单分散颗粒10的方法,包括:将离子表面活性剂(优选十六烷基三乙基溴化铵)与无机盐(优选硫酸钠)在盐酸中混合;和将助溶剂与非离子表面活性剂(优选聚环氧烷)和氧化物源(优选TEOS)混合;并将两者混合在一起。

著录项

  • 公开/公告号GB2507983A

    专利类型

  • 公开/公告日2014-05-21

    原文格式PDF

  • 申请/专利权人 NANOSCAPE AG;

    申请/专利号GB20120020556

  • 申请日2012-11-15

  • 分类号C01B37/02;A61K9/50;A61K47/02;B01J13/02;C01B33/12;

  • 国家 GB

  • 入库时间 2022-08-21 15:35:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号